LogicInk partners with the 221b Foundation to develop instrument-free CRISPR diagnostic for COVID-19
Non-invasive, Saliva-based COVID-19 CRISPR Biosensor to Provide Clinical Performance Comparable to Benchmark Standard Tests without Need for Power or Instrumentation CAMBRIDGE, Mass....